• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Possible regression of left ventricular hypertrophy during antihypertensive treatment with diuretics and/or beta blockers.

作者信息

Cherchi A, Sau F, Seguro C

出版信息

J Clin Hypertens. 1987 Jun;3(2):216-25.

PMID:2886561
Abstract

The possible regression of left ventricular hypertrophy (LVH) during treatment with diuretics and/or beta blockers was assessed in 78 hypertensive patients by echocardiography. Five groups of patients were treated, respectively, with diuretics alone, chlorthalidone plus SR oxprenolol, acebutolol followed by atenolol, timolol alone, or atenolol alone. All patients, except those receiving acebutolol had a significantly reduced LV mass within 12 months. Acebutolol did not modify LV mass even after 24 months, in spite of its antihypertensive efficacy. The reduction of LV mass was due to a decrease in wall thickness after administration of beta blockers and a decrease in LV dimension after chlorthalidone. Normalization of LV mass (less than 130 g/m2) occurred only in 31% of patients. LV mass was not significantly modified in patients with normal mass in pretreatment condition. The decrease of LV mass correlated with a decrease in cardiac output but not with the reduction in blood pressure. In conclusion, LV systolic function showed a tendency toward improvement after long-term antihypertensive therapy.

摘要

相似文献

1
Possible regression of left ventricular hypertrophy during antihypertensive treatment with diuretics and/or beta blockers.
J Clin Hypertens. 1987 Jun;3(2):216-25.
2
Effects of four antihypertensive monotherapies on cardiac mass and function in hypertensive patients with left ventricular hypertrophy: randomized prospective study.四种抗高血压单药治疗对左心室肥厚高血压患者心脏质量和功能的影响:随机前瞻性研究
Croat Med J. 2002 Dec;43(6):672-9.
3
[Chronology of regression of hypertensive ventricular hypertrophy during antihypertensive therapy with beta blockers].[β受体阻滞剂降压治疗期间高血压性心室肥厚消退的时间顺序]
Cardiologia. 1994 Jul;39(7):473-9.
4
[Electrocardiographic and echocardiographic changes during antihypertensive therapy].[抗高血压治疗期间的心电图和超声心动图变化]
Cardiologia. 1990 Dec;35(12):1015-22.
5
Effects of chronic administration of the fixed combination slow-release oxprenolol-chlorthalidone on left ventricular hypertrophy in hypertensive patients. Echocardiographic study.
Int J Clin Pharmacol Ther Toxicol. 1988 Mar;26(3):148-52.
6
[Regression of left heart hypertrophy in arterial hypertension: principles, experimental and clinical findings].[动脉高血压中左心室肥厚的消退:原理、实验及临床研究结果]
Z Kardiol. 1985;74 Suppl 7:153-69.
7
[Effects of indenolol on left ventricular mass in patients with essential arterial hypertension].
Cardiologia. 1990 Nov;35(11):925-30.
8
[Regression of left ventricular mass in arterial hypertension. Efficacy of 3 different treatment protocols].
Med Clin (Barc). 1992 Mar 21;98(11):401-4.
9
[The regression of left ventricular hypertrophy during the treatment of hypertension with different classes of beta blockers].[不同类别β受体阻滞剂治疗高血压过程中左心室肥厚的消退情况]
Vutr Boles. 1990;29(6):40-4.
10
Special considerations in the elderly patient.老年患者的特殊注意事项。
J Hum Hypertens. 1990 Dec;4 Suppl 5:7-10.

引用本文的文献

1
Regression of cardiac hypertrophy in health and disease: mechanisms and therapeutic potential.心脏肥大在健康和疾病中的消退:机制和治疗潜力。
Nat Rev Cardiol. 2023 May;20(5):347-363. doi: 10.1038/s41569-022-00806-6. Epub 2023 Jan 4.
2
Empagliflozin Disrupts a Tnfrsf12a-Mediated Feed Forward Loop That Promotes Left Ventricular Hypertrophy.恩格列净破坏了 Tnfrsf12a 介导的促进左心室肥厚的正反馈环。
Cardiovasc Drugs Ther. 2022 Aug;36(4):619-632. doi: 10.1007/s10557-021-07190-2. Epub 2021 Apr 22.
3
Left ventricular mass changes with nicardipine therapy in essential hypertension.
原发性高血压患者使用尼卡地平治疗时左心室质量的变化。
Cardiovasc Drugs Ther. 1989 Aug;3(4):525-8. doi: 10.1007/BF01865511.